Article
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.
PloS one - 1 Jan 2013
Harrington Michael G, Chiang Jiarong, Pogoda Janice M, Gomez Megan, Thomas Kris, Marion Sarah Deboard, Miller Karen J, Siddarth Prabha, Yi Xinyao, Zhou Feimeng, Lee Sherri, Arakaki Xianghong, Cowan Robert P, Tran Thao, Charleswell Cherise, Ross Brian D, Fonteh Alfred N
Abstract excerpt
BACKGROUND: Early treatment of Alzheimer's disease may reduce its devastating effects. By focusing research on asymptomatic individuals with Alzheimer's disease pathology (the preclinical stage), earlier indicators of disease may be discovered. Decreasing cerebrospinal fluid beta-amyloid42 is the first indicator of preclinical disorder, but it is not known which pathology causes the first clinical effects. Our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
